Cryo-Cell Intl (NYSEARCA:CCEL) Q3 Profit Surges Past Estimates on Flat Revenue
Cryo-Cell (CCEL) Q3 EPS crushed estimates at $0.16, but revenue stayed flat at $7.82M. See the profit surprise, market reaction, and key risks.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill